Free Trial

GlycoMimetics (GLYC) Insider Trading & Ownership

→ What is Medicare Supplement Insurance? (From Tranzact) (Ad)
Free GLYC Stock Alerts
$1.71
-0.15 (-8.06%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

GlycoMimetics (NASDAQ:GLYC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$116,295.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$7,215.00
Get GLYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling GlycoMimetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GLYC Insider Buying and Selling by Quarter

Ad Insider Financial
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Simply tap here now to subscribe and start getting "Insider Financial Advantage"

GlycoMimetics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/21/2023Edwin RockInsiderBuy35,000$1.38$48,300.00  
5/17/2023Brian M HahnCFOSell3,700$1.95$7,215.00  
5/10/2023Daniel M JuniusDirectorBuy30,000$1.56$46,800.00  
5/8/2023Bruce S JohnsonSVPBuy13,500$1.57$21,195.00  
(Data available from 1/1/2013 forward)

GLYC Insider Trading Activity - Frequently Asked Questions

Who is on GlycoMimetics's Insider Roster?

The list of insiders at GlycoMimetics includes Brian M Hahn, Bruce S Johnson, Daniel M Junius, Edwin Rock, John L Magnani, Patricia S Andrews, Public Equities L.P. Invus, and Scott D Sandell. Learn more on insiders at GLYC.

What percentage of GlycoMimetics stock is owned by insiders?

8.70% of GlycoMimetics stock is owned by insiders. Learn more on GLYC's insider holdings.

Which GlycoMimetics insiders have been buying company stock?

The following insiders have purchased GLYC shares in the last 24 months: Bruce S Johnson ($21,195.00), Daniel M Junius ($46,800.00), Edwin Rock ($438,800.00), and Public Equities L.P. Invus ($2,981,601.24).

How much insider buying is happening at GlycoMimetics?

Insiders have purchased a total of 1,749,951 GLYC shares in the last 24 months for a total of $3,488,396.24 bought.

Which GlycoMimetics insiders have been selling company stock?

The following insiders have sold GLYC shares in the last 24 months: Brian M Hahn ($7,215.00), and Scott D Sandell ($2,845,225.14).

How much insider selling is happening at GlycoMimetics?

Insiders have sold a total of 901,892 GlycoMimetics shares in the last 24 months for a total of $2,852,440.14 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:GLYC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Better than Bitcoin? The Biotech Stock with 46,751% Potential
Behind the Markets